S
Sasithon Pukrittayakamee
Researcher at Mahidol University
Publications - 209
Citations - 13552
Sasithon Pukrittayakamee is an academic researcher from Mahidol University. The author has contributed to research in topics: Malaria & Plasmodium falciparum. The author has an hindex of 60, co-authored 195 publications receiving 11873 citations. Previous affiliations of Sasithon Pukrittayakamee include John Radcliffe Hospital & Novartis.
Papers
More filters
Posted ContentDOI
Clinical antiviral efficacy of remdesivir and casirivimab/imdevimab against the SARS-CoV-2 Delta and Omicron variants
Podjanee Jittamala,William Hk Schilling,Julie Watson,Viravarn Luvira,Tanaya Siripoon,Thundon Ngamprasertchai,P.J. Almeida,Maneerat Ekkapongpisit,Claudia Andrea Cruz,James J. Callery,Sarita D. Boyd,Orawan Anunsittichai,Maliwan Hongsuwan,Yutatirat Singhaboot,Watcharee Pagornrat,Runch Tuntipaiboontana,V. Kruabkontho,Thatsanun Ngernseng,J. Tubprasert,Mohammad Yazid Abdad,Srisuda Keayarsa,Wanassanan Madmanee,Renato S. Aguiar,Franciele Martins Santos,Elizabeth M. Batty,Pongtorn Hanboonkunupakarn,Borimas Hanboonkunupakarn,Sakol Sookprome,Kittiyod Poovorawan,Mallika Imwong,Walter R. J. Taylor,Vasin Chotivanich,C. Sangketchon,W Ruksakul,Kesinee Chotivanich,Sasithon Pukrittayakamee,A. Dondorp,Day +37 more
TL;DR: Parenteral remdesivir accelerates viral clearance in early symptomatic COVID-19 despite substantially reduced in vitro activities, casirivimab/imdevimab retains in vivo antiviral activity against CO VID-19 infections caused by currently prevalent Omicron subvariants.
Journal ArticleDOI
Diagnosis of Murine Typhus by Serology in Peninsular Malaysia: A Case Report Where Rickettsial Illnesses, Leptospirosis and Dengue Co-Circulate
Yazli Yuhana,Ampai Tanganuchitcharnchai,Pimpan Sujariyakul,Piengchan Sonthayanon,Kesinee Chotivanich,Daniel H. Paris,Sasithon Pukrittayakamee,Stuart D. Blacksell,Stuart D. Blacksell,Borimas Hanboonkunupakarn +9 more
TL;DR: This case highlights the importance of considering murine typhus as a diagnostic in cases of acute febrile illness in urban and sub-urban areas, such as that of in Peninsular Malaysia.
Posted ContentDOI
Pharmacometric assessment of the in-vivo antiviral activity of ivermectin in early symptomatic COVID-19
William Hk Schilling,Podjanee Jittamala,Julie Watson,Maneerat Ekkapongpisit,Tanaya Siripoon,Thundon Ngamprasertchai,Viravarn Luvira,S. Pongwilai,Claudia Andrea Cruz,James J. Callery,Sarita D. Boyd,V. Kruabkontho,Thatsanun Ngernseng,J. Tubprasert,Mohammad Yazid Abdad,Nattaporn Piaraksa,Kanokon Suwannasin,Pongtorn Hanboonkunupakarn,Borimas Hanboonkunupakarn,Sakol Sookprome,Kittiyod Poovorawan,Janjira Thaipadungpanit,Stuart D. Blacksell,Mallika Imwong,Joel Tarning,Walter R. J. Taylor,Vasin Chotivanich,C. Sangketchon,W Ruksakul,Kesinee Chotivanich,Mauro M. Teixeira,Sasithon Pukrittayakamee,A. Dondorp,N P Day,Watcharapong Piyaphanee,Weerapong Phumratanaprapin,N J White,Platcov +37 more
TL;DR: High dose ivermectin did not have measurable antiviral activity in early symptomatic COVID-19, and viral clearance rate was measured in this way to determine whether this drug is a valuable treatment for SARS-CoV-2 infection.
Journal ArticleDOI
Cohort profile: molecular signature in pregnancy (MSP): longitudinal high-frequency sampling to characterise cross-omic trajectories in pregnancy in a resource-constrained setting.
Tobias Brummaier,Basirudeen Syed Ahamed Kabeer,Pornpimon Wilaisrisak,Mupawjay Pimanpanarak,Aye Kyi Win,Sasithon Pukrittayakamee,Alexandra K Marr,Tomoshige Kino,Souhaila Al Khodor,Annalisa Terranegra,Verena I. Carrara,Verena I. Carrara,François Nosten,François Nosten,Jürg Utzinger,Jürg Utzinger,Damien Chaussabel,Daniel H. Paris,Daniel H. Paris,Rose McGready,Rose McGready +20 more
TL;DR: The molecular signature in pregnancy (MSP) cohort was established to characterise longitudinal, cross-omic trajectories in pregnant women from a resource constrained setting and more detailed knowledge on multiomic perturbations will ideally result in the development of diagnostic tools and ultimately lead to targeted interventions that may disproportionally benefit pregnantWomen from this resource-limited population.